TAG:
DP
Digital Pathology’s Next Wave May Be in Precision Medicine
By Scott Wallask | From the Volume XXXIII, No. 5 – April 13, 2026 Issue
We’ve noted before that the adoption of digital pathology has not been as swift or strong as originally predicted. Many factors contribute to that concern. This topic came up in a recent interview The Dark Report conducted with Imoge…
Director Blissfully Uninvolved with Finances of DP Rollout
By Scott Wallask | From the Volume XXXIII, No. 2 – February 9, 2026 Issue
One of the biggest aspects of a clinical laboratory switching from traditional glass slides to digital pathology is the potential cost of such a project. It’s difficult to provide a reliable range of how expensive digital pathology (DP) imple…
Pathologists Take Images to the Cloud
By Stephen Beale | From the Volume XXXII, No. 17 – December 8, 2025 Issue
CEO SUMMARY: Scaled-up operations, streamlined logistics, and potential cybersecurity benefits all present a valid argument for pathology practices to move their data to the cloud. Digital pathology in particular stands to gain from a cloud-based setup that allows remote v…
NYU Langone Rolls Out Digital Path in One Year
By Scott Wallask | From the Volume XXXII, No. 16 – November 17, 2025 Issue
CEO SUMMARY: During an ambitious one-year project, NYU Langone Health implemented full-scale digital pathology. Although the initiative was large, a key organizer insists that smaller diagnostic labs can use some of the same approaches. Two big lessons to convey: Document …
Lumea’s Digital Pathology Success Lands It on Inc. 5000
By Scott Wallask | From the Volume XXXII, No. 14 – October 6, 2025 Issue
Digital pathology company Lumea was perhaps the most notable entry from the clinical laboratory world to make it onto the Inc. 5000 list of the fastest growing private companies in America in 2025. Lumea placed mid-pack at No. 2,468 …
Deal Offers Signals about the Future of Digital Pathology
By Janette Wider | From the Volume XXXII, No. 13 – September 15, 2025 Issue
THE DIGITAL PATHOLOGY MARKET IS AT AN INFLECTION POINT, AND TEMPUS’ RECENT $81.25 MILLION ACQUISITION OF PAIGE underscores both the challenges and opportunities ahead. While the pandemic temporarily accelerated digital pathology adoption, with vendors raising large su…
Pathology Compensation in Different Settings, including Hospitals
By Robert Michel | From the Volume XXXII, No. 1 – January 6, 2025 Issue
CEO SUMMARY: This second installment on the series about boosting pathologist compensation uses data collected during a survey of 1,400 pathologists in 230 pathology practices by the Panel of National Pathology Leaders (PNPL). Two experienced pathology consultants identify the most effect…
Lab Innovators in Europe Have Solutions for USA
By Robert Michel | From the Volume XXXI, No. 13 – September 23, 2024 Issue
CEO SUMMARY: Rapid advances in a wide range of technologies over the past 15 years are enabling entrepreneurs to create transformative products for use by clinical laboratories and anatomic pathology groups. The Dark Report recently toured Europe to visit several such innovative companies…
Pioneering DP Companies Ended Up Being Acquired
By Robert Michel | From the Volume XXXI, No. 12 – September 3, 2024 Issue
CEO SUMMARY: One reason why the adoption of a full digital pathology solution has lagged behind expectations may be attributed to the fact that four of the pioneering companies did not survive as independent businesses. They were sold and not all the new owners continued investing and dev…
Why Many Pathologists Are Cautious about Digital Path
By Robert Michel | From the Volume XXXI, No. 12 – September 3, 2024 Issue
CEO SUMMARY: In many major academic centers and the nation’s largest regional pathology supergroups, use of whole slide images and digital pathology workflow are accepted and established. This is often because of benefits unsupported by a pure return on investment. The clinical gains ou…
CURRENT ISSUE
Volume XXXIII, No. 8 – June, 2026
Congress Returns to CLIA Reform with Proposed LDT Framework, and the Newly Filed Enhancing CLIA Act seeks to modernize clinical laboratory regulations. A newly introduced federal bill could signal the next chapter in the long-running debate over how laboratory developed tests (LDTs) should be regulated in the United States.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized